Loading…

Mapping of a dengue virus neutralizing epitope critical for the infectivity of all serotypes: insight into the neutralization mechanism

Laboratoire d’Ingénierie des Anticorps 1 , Unité de Biochimie Cellulaire 2 and Unité des Arbovirus et Virus des Fièvres Hémorragiques 3 , Institut Pasteur, Paris, France Département de Biologie des Agents Transmissibles, Centre de Recherche du Service de Santé des Armées, BP 87, 38702 La Tronche Ced...

Full description

Saved in:
Bibliographic Details
Published in:Journal of general virology 2001-08, Vol.82 (8), p.1885-1892
Main Authors: Thullier, Philippe, Demangel, Caroline, Bedouelle, Hugues, Megret, Francoise, Jouan, Alain, Deubel, Vincent, Mazie, Jean-Claude, Lafaye, Pierre
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c410t-8784c4f89163b0b23d530acb475331aa47f34a31ccb9350dc7b6a0cbd3bbbc273
cites cdi_FETCH-LOGICAL-c410t-8784c4f89163b0b23d530acb475331aa47f34a31ccb9350dc7b6a0cbd3bbbc273
container_end_page 1892
container_issue 8
container_start_page 1885
container_title Journal of general virology
container_volume 82
creator Thullier, Philippe
Demangel, Caroline
Bedouelle, Hugues
Megret, Francoise
Jouan, Alain
Deubel, Vincent
Mazie, Jean-Claude
Lafaye, Pierre
description Laboratoire d’Ingénierie des Anticorps 1 , Unité de Biochimie Cellulaire 2 and Unité des Arbovirus et Virus des Fièvres Hémorragiques 3 , Institut Pasteur, Paris, France Département de Biologie des Agents Transmissibles, Centre de Recherche du Service de Santé des Armées, BP 87, 38702 La Tronche Cedex, France 4 Author for correspondence: Philippe Thullier (at Centre de Recherche du Service de Santé des Armées). Fax +33 4 76 63 69 17. e-mail pthullier{at}yahoo.com Dengue virus infections are a growing public health concern and strategies to control the spread of the virus are urgently needed. The murine monoclonal antibody 4E11 might be of interest, since it neutralizes dengue viruses of all serotypes by binding to the 296–400 segment of the major dengue virus envelope glycoprotein (DE). When phage-displayed peptide libraries were screened by affinity for 4E11, phage clone C1 was selected with a 50% frequency. C1 shared three of nine residues with DE 306–314 and showed significant reactivity to 4E11 in ELISA. C1-induced antibodies cross-reacted with DE 296–400 in mice, suggesting that it was a structural equivalent of the native epitope of 4E11 on DE. Accordingly, 4E11 bound to the DE 306–314 synthetic peptide and this reaction was inhibited by DE 296–400 . Moreover, DE 306–314 could block dengue virus infection of target cells in an in vitro assay. A three-dimensional model of DE revealed that the three amino acids shared by DE 296–400 and C1 were exposed to the solvent and suggested that most of the amino acids comprising the 4E11 epitope were located in the DE 306–314 region. Since 4E11 blocked the binding of DE 296–400 to heparin, which is a highly sulfated heparan sulfate (HSHS) molecule, 4E11 may act by neutralizing the interaction of DE 306–314 with target cell-displayed HSHS. Our data suggest that the DE 306–314 segment is critical for the infectivity of all dengue virus serotypes and that molecules that block the binding of DE 306–314 to HSHS may be antiviral reagents of therapeutic interest.
doi_str_mv 10.1099/0022-1317-82-8-1885
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_71006833</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>71006833</sourcerecordid><originalsourceid>FETCH-LOGICAL-c410t-8784c4f89163b0b23d530acb475331aa47f34a31ccb9350dc7b6a0cbd3bbbc273</originalsourceid><addsrcrecordid>eNqFkc1O3DAUha2qqExpn6AS8qrqJq3_MnbYIdQ_CcQG1pbt3My4SuJgO6DhBXjtOswIlqzO4nz3WPKH0BdKvlPSND8IYayinMpKsUpVVKn6HVpRsa4rVvr3aPVCHKOPKf0jhApRyw_omNKSTSNW6OnKTJMfNzh02OAWxs0M-N7HOeER5hxN7x-XGiafwwTYRZ-9Mz3uQsR5C9iPHbjs733ePW_0PU4QQ95NkM5Km_xmm0vm8Iy_jJrsw4gHcFsz-jR8Qked6RN8PuQJuv318-biT3V5_fvvxfll5QQluVJSCSc61dA1t8Qy3tacGGeFrDmnxgjZcWE4dc42vCatk3ZtiLMtt9Y6JvkJ-rrfnWK4myFlPfjkoO_NCGFOWlJC1orzN0EqG1azZgH5HnQxpBSh01P0g4k7TYleROlFg140aMW00ouocnV6mJ_tAO3rzcFMAb7tgW35wAcfQW9gHHx5xPqgi6HXrf9O5p-o</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17925293</pqid></control><display><type>article</type><title>Mapping of a dengue virus neutralizing epitope critical for the infectivity of all serotypes: insight into the neutralization mechanism</title><source>Freely Accessible Science Journals</source><creator>Thullier, Philippe ; Demangel, Caroline ; Bedouelle, Hugues ; Megret, Francoise ; Jouan, Alain ; Deubel, Vincent ; Mazie, Jean-Claude ; Lafaye, Pierre</creator><creatorcontrib>Thullier, Philippe ; Demangel, Caroline ; Bedouelle, Hugues ; Megret, Francoise ; Jouan, Alain ; Deubel, Vincent ; Mazie, Jean-Claude ; Lafaye, Pierre</creatorcontrib><description>Laboratoire d’Ingénierie des Anticorps 1 , Unité de Biochimie Cellulaire 2 and Unité des Arbovirus et Virus des Fièvres Hémorragiques 3 , Institut Pasteur, Paris, France Département de Biologie des Agents Transmissibles, Centre de Recherche du Service de Santé des Armées, BP 87, 38702 La Tronche Cedex, France 4 Author for correspondence: Philippe Thullier (at Centre de Recherche du Service de Santé des Armées). Fax +33 4 76 63 69 17. e-mail pthullier{at}yahoo.com Dengue virus infections are a growing public health concern and strategies to control the spread of the virus are urgently needed. The murine monoclonal antibody 4E11 might be of interest, since it neutralizes dengue viruses of all serotypes by binding to the 296–400 segment of the major dengue virus envelope glycoprotein (DE). When phage-displayed peptide libraries were screened by affinity for 4E11, phage clone C1 was selected with a 50% frequency. C1 shared three of nine residues with DE 306–314 and showed significant reactivity to 4E11 in ELISA. C1-induced antibodies cross-reacted with DE 296–400 in mice, suggesting that it was a structural equivalent of the native epitope of 4E11 on DE. Accordingly, 4E11 bound to the DE 306–314 synthetic peptide and this reaction was inhibited by DE 296–400 . Moreover, DE 306–314 could block dengue virus infection of target cells in an in vitro assay. A three-dimensional model of DE revealed that the three amino acids shared by DE 296–400 and C1 were exposed to the solvent and suggested that most of the amino acids comprising the 4E11 epitope were located in the DE 306–314 region. Since 4E11 blocked the binding of DE 296–400 to heparin, which is a highly sulfated heparan sulfate (HSHS) molecule, 4E11 may act by neutralizing the interaction of DE 306–314 with target cell-displayed HSHS. Our data suggest that the DE 306–314 segment is critical for the infectivity of all dengue virus serotypes and that molecules that block the binding of DE 306–314 to HSHS may be antiviral reagents of therapeutic interest.</description><identifier>ISSN: 0022-1317</identifier><identifier>EISSN: 1465-2099</identifier><identifier>DOI: 10.1099/0022-1317-82-8-1885</identifier><identifier>PMID: 11457994</identifier><language>eng</language><publisher>England: Soc General Microbiol</publisher><subject>Amino Acid Sequence ; Animals ; Antibodies, Monoclonal - immunology ; Antibodies, Viral - immunology ; Dengue - therapy ; Dengue - virology ; Dengue virus ; Dengue Virus - immunology ; Dengue Virus - pathogenicity ; Epitope Mapping ; Epitopes - analysis ; Glycoproteins - immunology ; Glycoproteins - metabolism ; Heparitin Sulfate - metabolism ; Mice ; Models, Molecular ; Molecular Sequence Data ; Neutralization Tests ; Peptides - chemistry ; Protein Binding ; Species Specificity ; Viral Envelope Proteins - immunology ; Viral Envelope Proteins - metabolism</subject><ispartof>Journal of general virology, 2001-08, Vol.82 (8), p.1885-1892</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c410t-8784c4f89163b0b23d530acb475331aa47f34a31ccb9350dc7b6a0cbd3bbbc273</citedby><cites>FETCH-LOGICAL-c410t-8784c4f89163b0b23d530acb475331aa47f34a31ccb9350dc7b6a0cbd3bbbc273</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11457994$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Thullier, Philippe</creatorcontrib><creatorcontrib>Demangel, Caroline</creatorcontrib><creatorcontrib>Bedouelle, Hugues</creatorcontrib><creatorcontrib>Megret, Francoise</creatorcontrib><creatorcontrib>Jouan, Alain</creatorcontrib><creatorcontrib>Deubel, Vincent</creatorcontrib><creatorcontrib>Mazie, Jean-Claude</creatorcontrib><creatorcontrib>Lafaye, Pierre</creatorcontrib><title>Mapping of a dengue virus neutralizing epitope critical for the infectivity of all serotypes: insight into the neutralization mechanism</title><title>Journal of general virology</title><addtitle>J Gen Virol</addtitle><description>Laboratoire d’Ingénierie des Anticorps 1 , Unité de Biochimie Cellulaire 2 and Unité des Arbovirus et Virus des Fièvres Hémorragiques 3 , Institut Pasteur, Paris, France Département de Biologie des Agents Transmissibles, Centre de Recherche du Service de Santé des Armées, BP 87, 38702 La Tronche Cedex, France 4 Author for correspondence: Philippe Thullier (at Centre de Recherche du Service de Santé des Armées). Fax +33 4 76 63 69 17. e-mail pthullier{at}yahoo.com Dengue virus infections are a growing public health concern and strategies to control the spread of the virus are urgently needed. The murine monoclonal antibody 4E11 might be of interest, since it neutralizes dengue viruses of all serotypes by binding to the 296–400 segment of the major dengue virus envelope glycoprotein (DE). When phage-displayed peptide libraries were screened by affinity for 4E11, phage clone C1 was selected with a 50% frequency. C1 shared three of nine residues with DE 306–314 and showed significant reactivity to 4E11 in ELISA. C1-induced antibodies cross-reacted with DE 296–400 in mice, suggesting that it was a structural equivalent of the native epitope of 4E11 on DE. Accordingly, 4E11 bound to the DE 306–314 synthetic peptide and this reaction was inhibited by DE 296–400 . Moreover, DE 306–314 could block dengue virus infection of target cells in an in vitro assay. A three-dimensional model of DE revealed that the three amino acids shared by DE 296–400 and C1 were exposed to the solvent and suggested that most of the amino acids comprising the 4E11 epitope were located in the DE 306–314 region. Since 4E11 blocked the binding of DE 296–400 to heparin, which is a highly sulfated heparan sulfate (HSHS) molecule, 4E11 may act by neutralizing the interaction of DE 306–314 with target cell-displayed HSHS. Our data suggest that the DE 306–314 segment is critical for the infectivity of all dengue virus serotypes and that molecules that block the binding of DE 306–314 to HSHS may be antiviral reagents of therapeutic interest.</description><subject>Amino Acid Sequence</subject><subject>Animals</subject><subject>Antibodies, Monoclonal - immunology</subject><subject>Antibodies, Viral - immunology</subject><subject>Dengue - therapy</subject><subject>Dengue - virology</subject><subject>Dengue virus</subject><subject>Dengue Virus - immunology</subject><subject>Dengue Virus - pathogenicity</subject><subject>Epitope Mapping</subject><subject>Epitopes - analysis</subject><subject>Glycoproteins - immunology</subject><subject>Glycoproteins - metabolism</subject><subject>Heparitin Sulfate - metabolism</subject><subject>Mice</subject><subject>Models, Molecular</subject><subject>Molecular Sequence Data</subject><subject>Neutralization Tests</subject><subject>Peptides - chemistry</subject><subject>Protein Binding</subject><subject>Species Specificity</subject><subject>Viral Envelope Proteins - immunology</subject><subject>Viral Envelope Proteins - metabolism</subject><issn>0022-1317</issn><issn>1465-2099</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2001</creationdate><recordtype>article</recordtype><recordid>eNqFkc1O3DAUha2qqExpn6AS8qrqJq3_MnbYIdQ_CcQG1pbt3My4SuJgO6DhBXjtOswIlqzO4nz3WPKH0BdKvlPSND8IYayinMpKsUpVVKn6HVpRsa4rVvr3aPVCHKOPKf0jhApRyw_omNKSTSNW6OnKTJMfNzh02OAWxs0M-N7HOeER5hxN7x-XGiafwwTYRZ-9Mz3uQsR5C9iPHbjs733ePW_0PU4QQ95NkM5Km_xmm0vm8Iy_jJrsw4gHcFsz-jR8Qked6RN8PuQJuv318-biT3V5_fvvxfll5QQluVJSCSc61dA1t8Qy3tacGGeFrDmnxgjZcWE4dc42vCatk3ZtiLMtt9Y6JvkJ-rrfnWK4myFlPfjkoO_NCGFOWlJC1orzN0EqG1azZgH5HnQxpBSh01P0g4k7TYleROlFg140aMW00ouocnV6mJ_tAO3rzcFMAb7tgW35wAcfQW9gHHx5xPqgi6HXrf9O5p-o</recordid><startdate>20010801</startdate><enddate>20010801</enddate><creator>Thullier, Philippe</creator><creator>Demangel, Caroline</creator><creator>Bedouelle, Hugues</creator><creator>Megret, Francoise</creator><creator>Jouan, Alain</creator><creator>Deubel, Vincent</creator><creator>Mazie, Jean-Claude</creator><creator>Lafaye, Pierre</creator><general>Soc General Microbiol</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7U9</scope><scope>H94</scope><scope>7X8</scope></search><sort><creationdate>20010801</creationdate><title>Mapping of a dengue virus neutralizing epitope critical for the infectivity of all serotypes: insight into the neutralization mechanism</title><author>Thullier, Philippe ; Demangel, Caroline ; Bedouelle, Hugues ; Megret, Francoise ; Jouan, Alain ; Deubel, Vincent ; Mazie, Jean-Claude ; Lafaye, Pierre</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c410t-8784c4f89163b0b23d530acb475331aa47f34a31ccb9350dc7b6a0cbd3bbbc273</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2001</creationdate><topic>Amino Acid Sequence</topic><topic>Animals</topic><topic>Antibodies, Monoclonal - immunology</topic><topic>Antibodies, Viral - immunology</topic><topic>Dengue - therapy</topic><topic>Dengue - virology</topic><topic>Dengue virus</topic><topic>Dengue Virus - immunology</topic><topic>Dengue Virus - pathogenicity</topic><topic>Epitope Mapping</topic><topic>Epitopes - analysis</topic><topic>Glycoproteins - immunology</topic><topic>Glycoproteins - metabolism</topic><topic>Heparitin Sulfate - metabolism</topic><topic>Mice</topic><topic>Models, Molecular</topic><topic>Molecular Sequence Data</topic><topic>Neutralization Tests</topic><topic>Peptides - chemistry</topic><topic>Protein Binding</topic><topic>Species Specificity</topic><topic>Viral Envelope Proteins - immunology</topic><topic>Viral Envelope Proteins - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Thullier, Philippe</creatorcontrib><creatorcontrib>Demangel, Caroline</creatorcontrib><creatorcontrib>Bedouelle, Hugues</creatorcontrib><creatorcontrib>Megret, Francoise</creatorcontrib><creatorcontrib>Jouan, Alain</creatorcontrib><creatorcontrib>Deubel, Vincent</creatorcontrib><creatorcontrib>Mazie, Jean-Claude</creatorcontrib><creatorcontrib>Lafaye, Pierre</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of general virology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Thullier, Philippe</au><au>Demangel, Caroline</au><au>Bedouelle, Hugues</au><au>Megret, Francoise</au><au>Jouan, Alain</au><au>Deubel, Vincent</au><au>Mazie, Jean-Claude</au><au>Lafaye, Pierre</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Mapping of a dengue virus neutralizing epitope critical for the infectivity of all serotypes: insight into the neutralization mechanism</atitle><jtitle>Journal of general virology</jtitle><addtitle>J Gen Virol</addtitle><date>2001-08-01</date><risdate>2001</risdate><volume>82</volume><issue>8</issue><spage>1885</spage><epage>1892</epage><pages>1885-1892</pages><issn>0022-1317</issn><eissn>1465-2099</eissn><abstract>Laboratoire d’Ingénierie des Anticorps 1 , Unité de Biochimie Cellulaire 2 and Unité des Arbovirus et Virus des Fièvres Hémorragiques 3 , Institut Pasteur, Paris, France Département de Biologie des Agents Transmissibles, Centre de Recherche du Service de Santé des Armées, BP 87, 38702 La Tronche Cedex, France 4 Author for correspondence: Philippe Thullier (at Centre de Recherche du Service de Santé des Armées). Fax +33 4 76 63 69 17. e-mail pthullier{at}yahoo.com Dengue virus infections are a growing public health concern and strategies to control the spread of the virus are urgently needed. The murine monoclonal antibody 4E11 might be of interest, since it neutralizes dengue viruses of all serotypes by binding to the 296–400 segment of the major dengue virus envelope glycoprotein (DE). When phage-displayed peptide libraries were screened by affinity for 4E11, phage clone C1 was selected with a 50% frequency. C1 shared three of nine residues with DE 306–314 and showed significant reactivity to 4E11 in ELISA. C1-induced antibodies cross-reacted with DE 296–400 in mice, suggesting that it was a structural equivalent of the native epitope of 4E11 on DE. Accordingly, 4E11 bound to the DE 306–314 synthetic peptide and this reaction was inhibited by DE 296–400 . Moreover, DE 306–314 could block dengue virus infection of target cells in an in vitro assay. A three-dimensional model of DE revealed that the three amino acids shared by DE 296–400 and C1 were exposed to the solvent and suggested that most of the amino acids comprising the 4E11 epitope were located in the DE 306–314 region. Since 4E11 blocked the binding of DE 296–400 to heparin, which is a highly sulfated heparan sulfate (HSHS) molecule, 4E11 may act by neutralizing the interaction of DE 306–314 with target cell-displayed HSHS. Our data suggest that the DE 306–314 segment is critical for the infectivity of all dengue virus serotypes and that molecules that block the binding of DE 306–314 to HSHS may be antiviral reagents of therapeutic interest.</abstract><cop>England</cop><pub>Soc General Microbiol</pub><pmid>11457994</pmid><doi>10.1099/0022-1317-82-8-1885</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0022-1317
ispartof Journal of general virology, 2001-08, Vol.82 (8), p.1885-1892
issn 0022-1317
1465-2099
language eng
recordid cdi_proquest_miscellaneous_71006833
source Freely Accessible Science Journals
subjects Amino Acid Sequence
Animals
Antibodies, Monoclonal - immunology
Antibodies, Viral - immunology
Dengue - therapy
Dengue - virology
Dengue virus
Dengue Virus - immunology
Dengue Virus - pathogenicity
Epitope Mapping
Epitopes - analysis
Glycoproteins - immunology
Glycoproteins - metabolism
Heparitin Sulfate - metabolism
Mice
Models, Molecular
Molecular Sequence Data
Neutralization Tests
Peptides - chemistry
Protein Binding
Species Specificity
Viral Envelope Proteins - immunology
Viral Envelope Proteins - metabolism
title Mapping of a dengue virus neutralizing epitope critical for the infectivity of all serotypes: insight into the neutralization mechanism
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-30T01%3A22%3A39IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Mapping%20of%20a%20dengue%20virus%20neutralizing%20epitope%20critical%20for%20the%20infectivity%20of%20all%20serotypes:%20insight%20into%20the%20neutralization%20mechanism&rft.jtitle=Journal%20of%20general%20virology&rft.au=Thullier,%20Philippe&rft.date=2001-08-01&rft.volume=82&rft.issue=8&rft.spage=1885&rft.epage=1892&rft.pages=1885-1892&rft.issn=0022-1317&rft.eissn=1465-2099&rft_id=info:doi/10.1099/0022-1317-82-8-1885&rft_dat=%3Cproquest_cross%3E71006833%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c410t-8784c4f89163b0b23d530acb475331aa47f34a31ccb9350dc7b6a0cbd3bbbc273%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=17925293&rft_id=info:pmid/11457994&rfr_iscdi=true